Isoniazid prophylaxis for pulmonary tuberculosis in chinese patients with rheumatoid arthritis receiving long term methotrexate therapy

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 1, 2009, Pages 138-140

  Xie, Qi Bing ^a   Wen, F Q ^a   Yin, Geng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Isoniazid; Prophylaxis; Rheumatoid arthritis; Tuberculosis

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; CHEMOPROPHYLAXIS; CONTROLLED STUDY; HUMAN; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHEMOPREVENTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISONIAZID; METHOTREXATE; MIDDLE AGED; TIME FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 59549098919     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Takayanagi N, Tsuchiya Y. Tokunaga D, et al. Pulmonary infections in patients with rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi,2007; 45(6): 465-743.
2. Moriuchi Y Kamihara S, Sotoh T, et al. Infection prophylaxis in patients with haematological malignancies-successful prophylaxis of tuberculosis with isoniazid. Rinsho Ketsueki, 1991i32(4):199-204.
3. Hernandez-Cruz B, Ponce-de-Leon-Rosales S, Sifuentes-Oso- mioj, etal. Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case control study. Clin Exp Rheumatol,1999; 17(1): 81-7.
4. Udwadia ZF. India. In: Davies PDO, ed. Clinical Tuberculosis. London: Chapman and Hall,1998:591-605.
5. Chinese source
6. Seong SS, Choi CB, Woo JH, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol, 2007; 34(4): 706-711.
7. Yamada T, Nakajima A, Inoue E, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis,2006,65(12), 1661-1663.
8. Lim HJ, Okwera A, Mayanja-Kizza H, et al. Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults. HIV Clin Trials,2006; 7(4): 172- 183.
9. Yildiz A, Sukru Sever M, Turkmen A, et al. Tuberculosis after renal transplantation, experience of one Turkish centre. Nephrol Dial Transplant,1998; 13(7): 1872-1875.
10. Mor A, Bingham CO, Kishimoto M, et al. Methotrexate combined with isoniazid therapy for latent tuberculosis is well tolerated in rheumatoid arthritis patients, experience from an urban arthritis clinic. Ann Rheum Dis,2008; 67(4): 462-465.
11. Vilcheze C, Jacobs WR Jr. The mechanism of isoniazid killing, clarity through the scope of genetics. Annu Rev Microbiol, 2007; 61(6): 35-50.
12. Telenti A. Genetics of drug resistance in tuberculosis. Clin Chest Med, 1997; 18(1): 55-64.
13. Parsons LM, Driscoll JR, Taber HW, et al. Drug resistance in tuberculosis. Infect Dis Clin North Am, 1997 j 11 (4) , 905- 28.
14. Nolan CM, Aitken ML, Elarth Am, etal. Active tuberculosis after isoniazid prophylaxis of South East Asian refugees. Am Rev Respir Dis,1986; 133(3): 431-436.